Generics And Biosimilars: Mapping The Biosimilars Regulatory Approval Pathway Against The Hatch-Waxman Act And Projecting Futures Effects On The Biologics Market And Patent Protection

Authors

  • Michael S. Montgomery

DOI:

https://doi.org/10.5195/lawreview.2014.339

Abstract

None

Downloads

Published

2015-05-21

How to Cite

Montgomery, Michael S. 2015. “Generics And Biosimilars: Mapping The Biosimilars Regulatory Approval Pathway Against The Hatch-Waxman Act And Projecting Futures Effects On The Biologics Market And Patent Protection”. University of Pittsburgh Law Review 75 (3). https://doi.org/10.5195/lawreview.2014.339.

Issue

Section

Note